Zenas BioPharma, Inc. Common Stock (ZBIO)

Zenas BioPharma, Inc. Common Stock (ZBIO) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.8B; returns 1 day -4.8%, 1 week +8.2%, 1 year +7.4%.

Zenas BioPharma, Inc. (ZBIO) is a clinical-stage global biopharmaceutical company dedicated to the development and commercialization of transformative immunology-based therapies for patients with autoimmune diseases. The company's revenue generation is currently minimal, primarily stemming from licensing and collaboration agreements.

Groups ZBIO belongs to

• Biotechnology
• Healthcare
• Biopharmaceutical
• Clinical Stage Biotech
• Clinical Stage
• Autoimmune Diseases
• Immunotherapy
• Monoclonal Antibodies
• CNS Disorders
• Rare Diseases
• Neuroscience

ZBIO financial model: income statement, cash flow and balance sheet